Tag: microvascular complications of diabetes

COVID Delay of nAMD Treatment Less Harmful than Expected

Many people with neovascular age-related macular degeneration (nAMD) lost less vision than expected during treatment delays imposed by COVID-19, researchers say. The finding suggests that...

Aflibercept Won’t Help Vision in Early Diabetic Retinopathy

Intravitreal injections with aflibercept (Eylea) don’t improve the visual acuity of people with nonproliferative diabetic retinopathy (NPDR), researchers say. The treatments do reduce the risk...

Surgery Equals Drug Tx for Bleeding in Diabetic Retinopathy

In the treatment of vitreous hemorrhage from proliferative diabetic retinopathy, intraocular injection with anti–vascular endothelial growth factor (VEGF) shows similar efficacy to that of vitrectomy...

Ranibizumab Biosimilar Shows Equivalent Efficacy to Branded Drug for Neovascular AMD

NEW YORK (Reuters Health) – In a phase 3 study, the ranibizumab biosimilar SB11 demonstrated equivalent efficacy and similar safety and immunogenicity profiles compared with...

Fluocinolone Implant Real-World Experience Matches DME Trials

A fluocinolone acetonide implant (Iluvien) administered under real-world circumstances works just as well for diabetic macular edema (DME) as it did in clinical trials, a...

Dexamethasone for Macular Edema Unresponsive to Anti-VEGF

When diabetic macular edema does not improve with anti-vascular endothelial growth-factor (VEGF) therapy, a quick and complete switch to dexamethasone might help, results from a...

Cardio Risk Increases With Diabetic Retinopathy Progression

The risk for heart attack, stroke, and even death increases as the severity of diabetic retinopathy increases. Severe retinopathy is linked to a doubling of...